Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : 25 Baiya SARS-CoV-2 Vax 2
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : 3M Company
Deal Size : Not Applicable
Deal Type : Not Applicable
3M Adjuvant Boosts Immune Response to Plant-Based COVID-19 Vaccine in Thailand Clinical Trials
Details : Baiya’s SARS-CoV-2 Vax 2 is second-generation plant-produced vaccine modelled on prototype SARS-CoV-2 RBD antigen adjuvanted with 3M-052-AF-alum. Data from first cohort of 12 participants demonstrated no significant changes in vital signs during first ...
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Not Applicable
September 29, 2022
Lead Product(s) : 25 Baiya SARS-CoV-2 Vax 2
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : 3M Company
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?